Local control is improved with HDR-boost for localised prostate cancer

被引：0
|
作者：
Kragelj, B. [1 ]
Grmek, M. [2 ]
机构：
[1] Inst Oncol Ljubljana, Dept Radiotherapy, Ljubljana, Slovenia
[2] Univ Med Ctr Ljubljana, Dept Nucl Med, Ljubljana, Slovenia
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1244
引用
收藏
页码：S673 / S673
页数：1
相关论文
共 50 条
  • [1] HDR monotherapy for localised prostate cancer
    Hoskin, PJ
    Bownes, P
    Ostler, P
    Bryant, L
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S6 - S6
  • [2] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [3] Assessment of acute toxicity with HDR focal boost and whole gland SBRT in localised prostate cancer
    Padayachee, J.
    Liu, Z.
    Berlin, A.
    Helou, J.
    Winter, J.
    Kong, V.
    Glicksman, R.
    Raman, S.
    Weersink, R.
    Chung, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S508 - S509
  • [4] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
  • [5] C-ARM CONE-BEAM CT AND TRUS GUIDED HDR-BOOST FOR PROSTATE TREATMENT
    Westendorp, R.
    Nuver, T.
    van der Molen, A.
    Kosse, J.
    Immerzeel, J.
    Hoekstra, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S280 - S280
  • [6] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Kazi, Aleksandra
    Godwin, Guy
    Simpson, John
    Sasso, Giuseppe
    BMC CANCER, 2010, 10
  • [7] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Aleksandra Kazi
    Guy Godwin
    John Simpson
    Giuseppe Sasso
    BMC Cancer, 10
  • [8] Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre
    Lorimer, C.
    Ravi, B.
    Cowtan, F.
    Johns, A.
    Robinson, A.
    Nikapota, A.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E241 - E241
  • [9] SBRT vs SBRT plus HDR-boost: a prospective comparative analysis of toxicity, QoL and disease control
    Zaragoza, Laura
    Buchser, David
    Ruiz, Uxue
    Hernandez, Rosa
    Mascarell, Carlos
    Cacicedo, Jon
    Gomez-Iturriaga, Alfonso
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S422 - S423
  • [10] A prospective randomised trial of HDR brachytherapy boost in radical radiotherapy for localised carcinoma of the prostate
    Hoskin, P.
    Ostler, P.
    Bownes, P.
    Woodruffe, M.
    Philips, H.
    Motohashi, K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S148 - S148
12345